Laboratory tests | | | |
Anemia, Hb < 110 g/L, n (%) | 18 (60.0) | 21 (41.2) | .10 |
Median Hb concentration (range), g/L | 106 (72–142) | 112 (77–151) | .50 |
Ferritin | | | |
• Median level (range), μg/L | 103 (5–427) | 127 (16–407) | .93 |
• < 200 μg/L, n (%) | 18 (60.0) | 38 (74.5) | .17 |
Iron saturation < 0.21%, n (%) | 17 (56.7) | 26 (51.0) | .62 |
Albumin | | | |
• Median level (range), g/L | 33.0 (22–45) | 38.0 (22–50) | .029 |
• < 30 g/L, n (%) | 6 (20.0) | 5 (9.8) | .31 |
Inorganic phosphate | | | |
• Median level (range), μmol/L | 1.45 (0.16–2.36) | 1.39 (0.85–2.8) | .75 |
• < 1.45 μmol/L, n (%) | 15 (50.0) | 29 (56.9) | .55 |
Calcium-phosphate product < 2 mg2/dL2, n (%) | 25 (83.3) | 40 (78.4) | .59 |
Median alkaline phosphate level (range), IU/L | 104 (59–166) | 100 (50–180) | .27 |
LDL | | | |
• Median (range) level, mmol/L | 2.1 (1–4.6) | 2.0 (0.11–4.7) | .29 |
• < 2.0 mmol/L, n (%) | 17 (56.7) | 29 (56.9) | .98 |
Median HbA1c level (range), %† | 14 (5–50) | 6.8 (5.5–11.5) | .86 |
Medications, n (%) | | | |
Lipid-lowering agents | 21 (70.0) | 26 (51.0) | .09 |
ACEIs or ARBs | 26 (86.7) | 33 (64.7) | .04 |
Oral hypoglycemics | 10 (33.3) | 17 (33.3) | .83 |
Insulin | 11 (36.7) | 13 (25.5) | .42 |
EPO agents | 7 (23.3) | 11 (21.6) | .85 |
Calcium channel blockers | 14 (46.7) | 17 (33.3) | .33 |
β-Blockers | 9 (30.0) | 23 (45.1) | .11 |
Phosphate binders | 10 (33.3) | 6 (11.8) | .04 |